国际眼科纵览 ›› 2025, Vol. 49 ›› Issue (5): 394-400.doi: 10.3760/cma.i.cn115500-20250526-25511

• 综述 • 上一篇    

难治性糖尿病性黄斑水肿的生物标志物

赵博文 张锐 王伟   

  1. 河北省眼科医院 河北省眼科学重点实验室 河北省眼部疾病临床研究中心,河北邢台 054000
  • 出版日期:2025-10-22 发布日期:2025-10-22
  • 通讯作者: 王伟,Email:wwhym1995@126.com
  • 基金资助:
    难治性糖尿病性黄斑水肿;糖尿病视网膜病变;发病机制
    基金项目: 邢台市重点研发计划项目(2022zz074)

Biomarkers of refractory diabetic macular edema

Zhao Bowen, Zhang Rui, Wang Wei   

  1. Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Clinical Research Center for Eye Diseases, Xingtai Hebei 054000, China
  • Online:2025-10-22 Published:2025-10-22
  • Contact: Wang Wei, Email: wwhym1995@126.com
  • Supported by:
     Xingtai Key Research and Development Plan Project(2022zz074)

摘要: 糖尿病性黄斑水肿(diabetic macular edema,DME)的病理表现为视网膜外丛状层和内核层之间的液体积聚,导致患者视力受损。全身因素如超敏C反应蛋白、同型半胱氨酸和肌酐等能够早期识别难治性DME;眼内炎性反应介质和细胞因子如白细胞介素、单核细胞趋化因子等为调整难治性DME的治疗方案提供新的思路;而OCT及OCTA的影像学标志物可为判断预后提供参考。

关键词: 难治性糖尿病性黄斑水肿, 糖尿病视网膜病变, 发病机制

Abstract: The pathological manifestation of diabetic macular edema (DME) is the accumulation of fluid between the outer plexiform layer and the inner nuclear layer of the retina, resulting in visual impairment. Systemic factors such as high-sensitivity c-reactive protein, homocysteine and creatinine can identify refractory dme early; Intraocular inflammatory mediators and cytokines, such as interleukin and monocyte chemoattractant factor, provide new ideas for the treatment of refractory DME As well as OCT, OCTA and other imaging markers can provide a reference for the judgment of prognosis.

Key words: Refractory diabetic macular edema, Diabetic retinopathy, Pathogenesis